Functional Characterization of 34 CYP2A6 Allelic Variants by Assessment of Nicotine C-Oxidation and Coumarin 7-Hydroxylation Activities

被引:21
作者
Hosono, Hiroki [1 ]
Kumondai, Masaki [1 ]
Maekawa, Masamitsu [2 ]
Yamaguchi, Hiroaki [2 ]
Mano, Nariyasu [2 ]
Oda, Akifumi [3 ]
Hirasawa, Noriyasu [1 ]
Hiratsuka, Masahiro [1 ]
机构
[1] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi, Japan
[2] Tohoku Univ Hosp, Dept Pharmaceut Sci, Sendai, Miyagi, Japan
[3] Meijo Univ, Dept Biophys Chem, Fac Pharm, Nagoya, Aichi, Japan
关键词
HUMAN CYTOCHROME-P450 2A6; HUMAN LIVER-MICROSOMES; BLACK-AFRICAN DESCENT; IN-VIVO; GENETIC-POLYMORPHISM; JAPANESE SMOKERS; 5-FLUOROURACIL FORMATION; ENZYMATIC-ACTIVITY; LUNG-CANCER; METABOLISM;
D O I
10.1124/dmd.116.073494
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CYP2A6, amember of the cytochrome P450 (P450) family, is one of the enzymes responsible for the metabolism of therapeutic drugs and such tobacco components as nicotine, 4-(methylnitrosamino)-1-(3pyridyl)- 1-butanone, and N-nitrosodiethylamine. Genetic polymorphisms in CYP2A6 are associated with individual variation in smoking behavior, drug toxicities, and the risk of developing several cancers. In this study, we conducted an in vitro analysis of 34 allelic variants of CYP2A6 using nicotine and coumarin as representative CYP2A6 substrates. These variant CYP2A6 proteins were heterologously expressed in 293FT cells, and their enzymatic activitieswere assessed on the basis of nicotine C-oxidation and coumarin 7-hydroxylation activities. Among the 34 CYP2A6 variants, CYP2A6.2, CYP2A6.5, CYP2A6.6, CYP2A6.10, CYP2A6.26, CYP2A6.36, and CYP2A6.37 exhibited no enzymatic activity, whereas 14 other variants exhibited markedly reduced activity toward both nicotine and coumarin. These comprehensive in vitro findings may provide useful insight into individual differences in smoking behavior, drug efficacy, and cancer susceptibility.
引用
收藏
页码:279 / 285
页数:7
相关论文
共 38 条
[11]   Three haplotypes associated with CYP2A6 phenotypes in Caucasians [J].
Haberl, M ;
Anwald, B ;
Klein, K ;
Weil, R ;
Fuss, C ;
Gepdiremen, A ;
Zanger, UM ;
Meyer, UA ;
Wojnowski, L .
PHARMACOGENETICS AND GENOMICS, 2005, 15 (09) :609-624
[12]   Functional Characterization of Allelic Variants of Polymorphic Human Cytochrome P450 2A6 (CYP2A6*5,*7,*8,*18,*19, and*35) [J].
Han, Songhee ;
Choi, Seunghye ;
Chun, Young-Jin ;
Yun, Chul-Ho ;
Lee, Chang Hoon ;
Shin, Hee Jung ;
Na, Han Sung ;
Chung, Myeon Woo ;
Kim, Donghak .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (03) :394-399
[13]   In Vitro Assessment of the Allelic Variants of Cytochrome P450 [J].
Hiratsuka, Masahiro .
DRUG METABOLISM AND PHARMACOKINETICS, 2012, 27 (01) :68-84
[14]   A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent [J].
Ho, Man Ki ;
Mwenifumbo, Jill C. ;
Zhao, Bin ;
Gillam, Elizabeth M. J. ;
Tyndale, Rachel F. .
PHARMACOGENETICS AND GENOMICS, 2008, 18 (01) :67-75
[15]   CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers [J].
Hosono, Hiroki ;
Kumondai, Masaki ;
Arai, Tomio ;
Sugimura, Haruhiko ;
Sasaki, Takamitsu ;
Hirasawa, Noriyasu ;
Hiratsuka, Masahiro .
DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (04) :263-268
[16]   HUMAN KIDNEY METHOXYFLURANE AND SEVOFLURANE METABOLISM - INTRARENAL FLUORIDE PRODUCTION AS A POSSIBLE MECHANISM OF METHOXYFLURANE NEPHROTOXICITY [J].
KHARASCH, ED ;
HANKINS, DC ;
THUMMEL, KE .
ANESTHESIOLOGY, 1995, 82 (03) :689-699
[17]   CYP2A6*6, a novel polymorphism in cytochrome P450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity [J].
Kitagawa, K ;
Kunugita, N ;
Kitagawa, M ;
Kawamoto, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :17830-17835
[18]  
Kiyotani Kazuma, 2002, Drug Metab Pharmacokinet, V17, P482, DOI 10.2133/dmpk.17.482
[19]  
Komatsu T, 2000, DRUG METAB DISPOS, V28, P1457
[20]   Genetic Polymorphisms of CYP2A6 in a Case-Control Study on Bladder Cancer in Japanese Smokers [J].
Kumondai, Masaki ;
Hosono, Hiroki ;
Orikasa, Kazuhiko ;
Arai, Yoichi ;
Arai, Tomio ;
Sugimura, Haruhiko ;
Ozono, Seiichiro ;
Sugiyama, Takayuki ;
Takayama, Tatsuya ;
Sasaki, Takamitsu ;
Hirasawa, Noriyasu ;
Hiratsuka, Masahiro .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (01) :84-89